SCNI vs SNA · P/E 0.2, rev $1.3M vs P/E 17, rev $1.33B
Scinai Immunotherapeutics Ltd (SCNI) versus Snap-On Inc (SNA) — a side-by-side from cached financials, not a winner call.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Latest reported SNA revenue for 2026-07-04 was $1.33B. Net income was $260.6M. Revenue was up 2.0% from 2026-04-04 to 2026-07-04. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
SCNI currently screens at market cap $1.8M and trailing P/E 0.2. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Not investment advice. Open the SCNI and SNA stock pages for the full models.
Not investment advice.